Lanka Hospitals, the internationally accredited healthcare provider reached another milestone recently when the hospital’s Blood Cancer Centre that provides treatment for blood cancer and other blood disorders reached its 7th anniversary this month.
Lanka Hospitals is the only private hospital with a dedicated Centre for blood cancer care, and offers treatment for Leukaemia, Lymphoma, Myeloma and bone marrow transplants. The dedicated centre which was established in October 2013, is equipped with all the required medical and surgical facilities to diagnose and treat patients to the highest international medical standard.
“Our Blood Cancer Centre is the only centre which offers the services of a Resident Clinical Haematologist/Haemato-Oncologist in addition to visiting General Oncologists, Hematologists and Transfusion Consultants,” Lanka Hospitals’ Group Chief Executive Officer, Deepthi Lokuarachchi stated.
“The Blood Cancer Centre has a dedicated in-patient, out-patient and day-care facility. We have maintained our services at a very high standard that is similar to blood cancer treatment facilities in advanced countries,” Lanka Hospitals’ Director Medical Services Dr. Wimal Karandagoda stated.
In November 2015, Lanka Hospital blood cancer Centre introduced a Multi-Disciplinary Team (MDT) meeting, a mechanism put forward for careful review and decision-making with regard to the treatment and diagnosis of patients with blood cancer and blood disorders.
“ We have cared for nearly 3,000 patients according to UK protocols and their response and survival parameters are on par with Western countries. In addition, Oncology trainees at the Cancer Institute in Maharagama have had their initial training in the sub-specialty of Haemato-Oncology at the Lanka Hospital’s Blood Cancer Centre,” Clinical Haematologist / Haemato-Oncologist, Dr. Saman Hewamana stated.
Lanka Hospitals’ Blood Cancer Centre also reached a milestone when it launched the Blood Cancer Care Fund in early 2019 to assist those who have blood cancer, by easing their financial burden of meeting the cost of treatment.
“We believe research is one of the key factors in improving patient outcomes. We have proven to have maintained response rates and survival parameters comparable to data from other European centres”, Senior Consultant Oncologist, Dr. Jayantha Balawardena stated.
0 comments: